AstraZeneca Pharma India Limited has informed the Exchange about General Updates
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
AstraZeneca Pharma India has informed the stock exchanges about the appointment of Mrs. Sandhya Tejaswini Amanna as Director - Legal, effective March 18, 2026. The appointment was approved by the Board based on the recommendation of the Nomination and Remuneration Committee. Mrs. Amanna is a seasoned legal professional with over two decades of experience across manufacturing, FMCG, and pharmaceutical sectors. She joins from Danone India, where she served as Head of Legal, Compliance and Secretarial, and holds an LLB from the University of Mumbai. The position is classified as Senior Management Personnel under SEBI Listing Regulations.
This is a routine senior management hire to strengthen the company's legal and compliance function. It is unlikely to have any material impact on the stock price or shareholder value, as it fills a key internal leadership role rather than signalling a strategic shift.